View 
FILTERS (0)
* Not connected to ResearchPool

MORE FILTERS

  
reports
Charlotte Vaisse ... (+4)
  • Charlotte Vaisse
  • Jean-Baptiste Rouphael
  • Luis de Toledo Heras
  • Thomas Zlowodzki

ODDO BHF Small & MIDCAP MORNING NEWS - 04/25/2024

Having flirted with the 495-point mark on Friday, which could have triggered an extension of the correction, the market has rebounded well since then. Our technical analysis highlights a configuration in which we are only at the start of a powerful rally. Target of 622 points for Stoxx 600 index (+11%) by the end of the year confirmed. Prefer banks to insurance companies in the short term. - ...

Charlotte Vaisse ... (+4)
  • Charlotte Vaisse
  • Jean-Baptiste Rouphael
  • Luis de Toledo Heras
  • Thomas Zlowodzki

ODDO BHF Small & MIDCAP MORNING NEWS - 25/04/2024

Après avoir frôlé vendredi la barre des 495 points qui aurait pu déclencher la poursuite de la correction, le marché a ensuite bien rebondi. Notre analyse technique met en lumière une configuration où nous ne serions qu’au début d’un rallye puissant. Objectif 622 points (+11%) d’ici à la fin de l’année confirmé sur le Stoxx 600. Préférer les banques aux assurances à court terme. - ...

Julian Dobrovolschi
  • Julian Dobrovolschi

Flow Traders : Blowout Q1 2024 results, expect strong share price reac...

>All line items materially above consensus forecast - FLOW came out with a set of blowout figures this morning, whereby all P&L line items came materially above consensus forecast. NTI in the quarter was € 127.1m, which is 57% above estimates and implying a material acceleration QoQ. The company does not break down NTI per region this time around, however we believe that both EMEA and US was strong given that both regions run crypto-trading operations. EBITDA came str...

ING Helpdesk
  • ING Helpdesk

Benelux Morning Notes

Azelis: Strong margin performance in weak trading results in 3% EBITA beat. BE Semiconductor Industries: 1Q24 results; prolonged downcycle. Coca-Cola Europacific Partners plc: Messy but good. DWS: Record breaking. Flow Traders: Crypto Kings. Fugro: Here we go again. Kinepolis: Weak start to the year, but a bit better than feared. UCB: Changes in the group executive committee. Unilever: Heading in the right direction. Vonovia: Disposal of 4,500 apartments for €700m. Wolters Kl...

Guy Sips ... (+9)
  • Guy Sips
  • Hilde Van Boxstael
  • Kristof Samoy
  • Lynn Hautekeete
  • Thibault Leneeuw
  • Thomas Couvreur
  • Thomas Vranken
  • Wim Hoste
  • Wim Lewi

Morning Notes : ADYEN NA, ASML NA, BESI NA, FLOW NA, FUR NA, HEIA NA, ...

: ADYEN NA, ASML NA, BESI NA, FLOW NA, FUR NA, HEIA NA, HOMI BB, KIN BB, VGP BB, WDP BB, XFAB FP, AZE BB, ONWD BB

Julian Dobrovolschi
  • Julian Dobrovolschi

Flow Traders : Digital assets save the quarter, with muted core ETP an...

>Conclusion: a quarter dominated mostly by the acceleration in digital assets - Q1 2024 looks to be a quarter that was dominated predominantly by the acceleration in the digital assets space, fuelled by the spot Bitcoin ETF approval at the start of 2024. Core ETP and single-bond trading market dynamics were mixed in Q1 2024, hence we expect a muted performance from these two asset classes. Overall, we forecast NTI of € 82.4m in the quarter, implying 13.3% growth QoQ. ...

Julian Dobrovolschi
  • Julian Dobrovolschi

Flow Traders : Fundamentals deteriorating further; Neutral reiterated

>Market (briefly) happy with Q4 2023 results, likely fearing cuts to dividend policy - Last Thursday (8 February) the shares popped c.7% intraday on fairly uneventful Q4 2023 results. The share price reaction came as a surprise to us, and many others. We believe the market was (temporarily) happy with FLOW reiterating its dividend policy of a 50% payout ratio of IFRS net profits. This came as a relief, as the street was fearing changes to the capital allocation policy...

Julian Dobrovolschi
  • Julian Dobrovolschi

Flow Traders : Top-line miss, profitability and net profit a tad bette...

>NTI missing the street by 6.9%, however norm. EBITDA 1.5bps better - Overall we think FLOW posted a mixed set of results in Q4 2023. Revenue came 6.9% below css expectations, however profitability was slightly ahead (1.5bps on norm. EBITDA), and net profit was 4.1% ahead of expectations (on norm. basis). The reason for bottom line beat was decline in the headcount over Q4 2023. As a consequence, the company had a good quarter in terms of cost management, which stacks...

Guy Sips ... (+6)
  • Guy Sips
  • Hilde Van Boxstael
  • Thomas Couvreur
  • Thomas Vranken
  • Wim Hoste
  • Wim Lewi

Morning Notes : ADYEN NA, BAR BB, FLOW NA, INGA NA, MONT BB, ONTEX BB,...

: ADYEN NA, BAR BB, FLOW NA, INGA NA, MONT BB, ONTEX BB, XIOR BB, BTLS BB, ONWD EN

Guy Sips ... (+6)
  • Guy Sips
  • Hilde Van Boxstael
  • Jacob Mekhael
  • Thomas Couvreur
  • Wim Hoste
  • Wim Lewi
Christophe-Raphaël Ganet ... (+3)
  • Christophe-Raphaël Ganet
  • Emmanuel Matot
  • Jeremy Garnier
Christophe-Raphaël Ganet ... (+3)
  • Christophe-Raphaël Ganet
  • Emmanuel Matot
  • Jeremy Garnier
Julian Dobrovolschi
  • Julian Dobrovolschi

Flow Traders : Q4 2023e preview; NTI of € 74m and EBITDA of € 16.7m

>Conclusion: market conditions not yet in the sweet spot, Neutral reiterated - - Q4 2023 volumes accelerated well across all end-markets on a QoQ basis, albeit from a low base. That said, the low volatility environment in the core ETP market was a clear drag to NTI. We expect a somewhat higher contribution to NTI this quarter from the single bond and digital assets trading strategy. Overall, we forecast NTI of € 74.1m in Q4 2023, up 10% QoQ, but still down c.36% YoY given ...

Michiel Declercq ... (+2)
  • Michiel Declercq
  • Thomas Couvreur
Loading...
New interest

Save your current filters as a new Interest

Please enter a name for this interest

Email alerts

Would you like to receive real-time email alerts when a new report is published under this interest?

Save This Search

These search results will show up under 'Saved searches' in the left panel

Please enter a name for this saved search

ResearchPool Subscriptions

Get the most out of your insights

Get in touch